We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$90.4M
AUM Growth
-$24.9M
Cap. Flow
+$39.7M
Cap. Flow %
43.96%
Top 10 Hldgs %
41.01%
Holding
168
New
38
Increased
23
Reduced
24
Closed
62

Top Buys

Rank Stock Value
1
ISRL
Isramco Inc
ISRL
+$12.1M
2
CTSH icon
Cognizant
CTSH
+$5.71M
3
KSU
Kansas City Southern
KSU
+$3.43M
4
PF
Pinnacle Foods, Inc.
PF
+$2.98M
5
IRBT
iRobot
IRBT
+$1.07M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$1.32M
2
INSM icon
Insmed
INSM
+$950K
3
IBKR icon
Interactive Brokers
IBKR
+$774K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$754K
5
NBIX icon
Neurocrine Biosciences
NBIX
+$702K

Sector Composition

Rank Sector Weight
1 Technology 17.51%
2 Consumer Discretionary 8.14%
3 Industrials 5.64%
4 Communication Services 5.16%
5 Healthcare 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBBY
101
PUT
Bed Bath & Beyond
BBBY
$512M
– –
-99,692
Closed -$58K
CSX icon
102
CSX Corp
CSX
$96B
– –
-25,416
Closed -$460K
CTO
103
CTO Realty Growth
CTO
$744M
– –
-37,227
Closed -$607K
DEA
104
Easterly Government Properties
DEA
$1.17B
– –
-5,564
Closed -$288K
DVN icon
105
Devon Energy
DVN
$49.8B
– –
-6,620
Closed -$243K
GIB icon
106
CGI
GIB
$14.5B
– –
-4,109
Closed -$213K
GOOGL icon
107
Alphabet (Google) Class A
GOOGL
$3.99T
– –
-4,780
Closed -$233K
IMMR icon
108
Immersion
IMMR
$256M
$0 ﹤0.01%
+48
New +$347
INSM icon
109
CALL
Insmed
INSM
$22.7B
– –
-27,800
Closed -$8K
INSM icon
110
Insmed
INSM
$22.7B
– –
-30,454
Closed -$950K
INSM icon
111
PUT
Insmed
INSM
$22.7B
– –
-46,500
Closed -$3K
INTC icon
112
PUT
Intel
INTC
$462B
– –
-45,200
Closed -$7K
JPM icon
113
JPMorgan Chase
JPM
$947B
– –
-2,660
Closed -$254K
KRG icon
114
Kite Realty
KRG
$5.99B
– –
-20,051
Closed -$406K
LPX icon
115
Louisiana-Pacific
LPX
$5.19B
– –
-11,235
Closed -$304K
NBIX icon
116
Neurocrine Biosciences
NBIX
$17.7B
– –
-11,469
Closed -$702K
NBR icon
117
CALL
Nabors Industries
NBR
$1.16B
– –
-234
Closed -$10K
NBR icon
118
Nabors Industries
NBR
$1.16B
– –
-351
Closed -$142K
NBR icon
119
PUT
Nabors Industries
NBR
$1.16B
– –
-228
Closed -$5K
NXPI icon
120
NXP Semiconductors
NXPI
$67.6B
– –
-542
Closed -$62.6K
OVV icon
121
Ovintiv
OVV
$16.6B
– –
-3,130
Closed -$184K
PTCT icon
122
CALL
PTC Therapeutics
PTCT
$6.29B
– –
-300
Closed -$1K
PTCT icon
123
PTC Therapeutics
PTCT
$6.29B
– –
-66,196
Closed -$1.32M
PTCT icon
124
PUT
PTC Therapeutics
PTCT
$6.29B
– –
-187,600
Closed -$412K
SHOO icon
125
Steven Madden
SHOO
$3.18B
– –
-7,095
Closed -$205K
3 4
5
6 7

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Worth Venture Partners held 168 positions worth $90.4M, down 22% from $115M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Worth Venture Partners deployed $39.7M of net new capital in Q4 2017, opening 38 new positions and adding to 23 existing holdings. Its largest new stake was Isramco Inc: 104,579 shares worth $45K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 6.6% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Interactive Brokers, an estimated $774K trimmed.

  • Worth Venture Partners's largest Q4 2017 buy was Isramco Inc: 104,579 shares worth $45K.
  • Worth Venture Partners added most to Skechers in Q4 2017, an estimated $939K increase.
  • Worth Venture Partners's biggest Q4 2017 reduction was Interactive Brokers, cutting an estimated $774K.
  • Worth Venture Partners fully exited PTC Therapeutics in Q4 2017, selling an estimated $1.32M.
  • Worth Venture Partners's ten largest holdings make up 41% of its $90.4M portfolio in Q4 2017.
  • Worth Venture Partners opened 38 new positions and closed 62 in Q4 2017.
  • Worth Venture Partners's portfolio value fell 22% quarter-over-quarter to $90.4M.

Based on Worth Venture Partners's 13F filing for Q4 2017, filed 1 Feb 2018.